图书简介

Section 1: The subject matter and approach to psychiatry; 1 Kay Redfield Jamison and Adam Ian Kaplin: The patient’s perspective; 2 Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public attitudes and the challenge of stigma; 3 Crick Lund, Dorte Bemme, and Judy Bass: Global mental health; 4 Pierre Pichot: The history of psychiatry as a medical specialty; 5 Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics for 21st century psychiatry; 6 Hans-Jurgen Moller: Foundations of phenomenology / descriptive psychopathology; 7 Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun: DSM-5 and ICD-11 classifications; 8 Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research; 9 Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of research evidence in clinical practice; 10 Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience based nomenclature for psychotropic drugs; Section 2: The scientific basis of psychiatric aetiology and treatment; 11 Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy; 12 Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging technologies; 13 Olaf Sporns: The connectome; 14 Trevor Sharp: Neurotransmitters and signalling; 15 Juan C. Leza, Javier R. Caso, and Borja Garcia-Bueno: Psychoneuroimmunology; 16 Caleb Webber: Functional genomics; 17 Anna Christina Nobre: Cognitive neuroscience: Principles and methods; 18 Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the human brain; 19 Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse: Development of brain stimulation; 20 Amy Chan and Rob Horne: Adherence to treatment in psychiatry; Section 3: Intellectual disabilities; 21 Anthony J. Holland: Core dimensions of intellectual disabilities; 22 Sally-Ann Cooper: Epidemiology and course of intellectual disabilities; 23 Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of intellectual disability: General issues and prevention; 24 Jose-Luis Ayuso-Mateos and Cary S. Kogan: Management and treatment of intellectual disability; Section 4: Autism spectrum disorders; 25 Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of autism spectrum disorders; 26 Emily J. H. Jones: Basic mechanisms and treatment targets for autism spectrum disorders; 27 Charles R. Newton: Epidemiology of autism; 28 Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman: Genetics of autism spectrum disorders; 29 Christine Eckera and Declan Murphy: Imaging of autism spectrum disorders; 30 Emily Simonoff: Management and treatment of autism spectrum disorders; Section 5: Attention deficit and hyperactivity disorder; 31 Eric Taylor: Core dimensions of attention deficit hyperactivity disorder; 32 Barbara Franke and Jan K. Buitelaar: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder; 33 Guilherme V. Polanczyk: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention; 34 Kate Langley and Anita Thapar: Genetics of attention deficit hyperactivity disorder; 35 Philip Shaw and Eszter Szekely: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan; 36 Alessandro Zuddas and Sara Carucci: Management and treatment of attention deficit hyperactivity disorder; Section 6: Motor disorders; 37 Davide Martino and Antonella Macerollo: Neurodevelopmental motor disorders; Section 7: Delirium, dementia, and other cognitive disorders; 38 Noel J. Buckley and George K. Tofaris: Pathways of neurodegeneration underlying dementia; 39 Ravi S. Bhat and Kenneth Rockwood: Delirium; 40 Ivan Koychev and John Gallacher: Alzheimer’s disease; 41 Akitoshi Takeda and Bruce Miller: Frontotemporal dementias; 42 Akin Nihat, TzeHow Mok, and John Collinge: Prion disease; 43 Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies; 44 Michele Hu and Fahd Baig: Dementia in Parkinson’s disease; 45 Russell L. Margolis: Dementia due to Huntington’s disease; 46 Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive impairment; 47 Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton: Traumatic brain injury; Section 8: Substance use disorders; 48 Trevor W. Robbins and Barry J. Everitt: Substance use disorders and the mechanisms of drug addiction; 49 Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of substance use disorders; 50 Wim van den Brink and Falk Kiefer: Alcohol use disorder; 51 Michael Farrell, Briony Larance, and Courtney Breen: Opiates: Heroin, methadone, buprenorphine; 52 David J. Castle: Cannabis and mental illness; 53 Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and other party drugs; 54 Adam Winstock and James Rucker: Psychedelics and dissociative substances; 55 Marcus Munafo and Meryem Grabski: Tobacco addiction; 56 Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of substance use and psychiatric disorders; Section 9: Schizophrenia and psychotic disorders; 57 Nancy C. Andreasen: The core dimensions of schizophrenia; 58 Assen Jablensky: Epidemiology and course of schizophrenia; 59 Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan: Genetics of schizophrenia; 60 Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan: Structural and functional neuroimaging of schizophrenia; 61 William S. Stone, Stephen V. Faraone and Ming T. Tsuang: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders; 62 Andreas Marneros: Delusional disorders; 63 Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and early intervention in psychotic disorders; 64 Herbert Y. Meltzer and William V. Bobo: Antipsychotic and anticholinergic drugs; 65 Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer: The treatment and management of patients with schizophrenia; Section 10: Mood disorders; 66 S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and differential diagnosis of mood disorders; 67 Lars Vedel Kessing: Epidemiology of mood disorders; 68 Gin S. Malhi: Primary prevention of mood disorders: Building a target for prevention strategies; Section 11: Bipolar disorder; 69 Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic mechanisms of and treatment targets for bipolar disorder; 70 Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of bipolar disorder; 71 Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar disorder; 72 Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz: Management and treatment of bipolar disorder; 73 Ian Jones and Arianna Di Florio: Perinatal psychiatry; Section 12: Depressive disorders; 74 Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic mechanisms of and treatment targets for depressive disorders; 75 Alison K. Merikangas and Kathleen R. Merikangas: Genetic epidemiology of depression in the molecular era; 76 Guy M. Goodwin and Michael Browning: Imaging of depressive disorders; 77 Philip J. Cowen: Management and treatment of depressive disorders; Section 13: Trauma and stress or related and adjustment disorders; 78 Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders; 79 Bruce S. McEwen: Basic mechanisms of and treatment targets for stress-related disorders; 80 Michael G. Gottschalk and Katharina Domschke: Genetics of stress-related disorders; 81 Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin: Imaging of stress-related disorders; 82 Maria Bragesjo, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson: Primary prevention and epidemiology of trauma and stress related disorders; 83 Leigh van den Heuvel and Soraya Seedat: Management and treatment of stress-related disorders; 84 Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement; 85 Deborah Davis and Elizabeth F. Loftus: Recovered memories and false memories; Section 14: Anxiety disorders; 86 Nastassja Koen and Dan J. Stein: Core dimensions of anxiety disorders; 87 Martien Kas and Berend Olivier: Basic mechanisms, genetics, targets and animal models for anxiety disorders; 88 Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and course of anxiety disorders; 89 Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety disorders; 90 Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety disorders; 91 Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen: The primary prevention of anxiety disorders; 92 David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety disorders; Section 15: Obsessive-compulsive and related disorders; 93 Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core dimensions of obsessive-compulsive disorder; 94 Eric Burguiere and Luc Mallet: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder; 95 Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar: Obsessive-compulsive disorder; 96 Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive disorder; 97 Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive disorder; 98 Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and treatment of obsessive-compulsive disorder; 99 Lorena Fernandez de la Cruz and David Mataix-Cols: Hoarding disorder; 100 Megan M. Kelly and Katharine A. Phillips: Body dysmorphic disorder; Section 16: Feeding and eating disorders; 101 Chris Fairburn and Rebecca Murphy: The eating disorders; 102 Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann: Basic mechanisms and potential for treatment of weight and eating disorders; 103 Katherine A Halmi: Epidemiology and primary prevention of feeding and eating disorders; 104 Christopher Huble, Cynthia Bulik, and Gerome Breen: Genetics of feeding and eating disorders; 105 Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye: Imaging of feeding and eating disorders; 106 Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.: Management and treatment of feeding and eating disorders; 107 Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb: Aetiology and management of obesity; 108 Alexander von Gontard: Elimination disorders in children and adolescents; Section 17: Sleep wake disorders; 109 David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson: Basic mechanisms of and treatment targets for sleep-wake disorders; 110 Kirstie Anderson: Diagnosis of sleep and circadian rhythm disorder; 111 Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg: Epidemiology of sleep-wake and primary prevention of its disorders; 112 Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman: Genetics of sleep-wake disorders; 113 Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders; 114 Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management of insomnia and circadian rhythm sleep-wake disorders; Section 18: Sexual function and sexual dysfunction; 115 Cynthia A. Graham and John Bancroft: The sexual dysfunctions and paraphilias; 116 Els Elaut and Gunter Heylens: Gender dysphoria; Section 19: Personality disorders; 117 Andrew E. Skodol and Leslie C. Morey: Core dimensions of personality pathology; 118 Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and treatment planning / targets for personality disorders; 119 Renato D. Alarcon and Brian A. Palmer: Personality disorders: Epidemiology and clinical course; 120 C. Robert Cloninger: Genetics of personality disorders; 121 Christian Paret and Christian Schmahl: Imaging of personality disorders; 122 Giles Newton-Howes and Roger Mulder: Treatment and management of personality disorder; Section 20: Impulse control and conduct disorders; 123 Donald W. Black: Impulse control and its disorders: including pathological gambling; 124 Stephen Scott and Melanie Palmer: Conduct disorders and antisocial personality disorder in childhood and adolescence; Section 21: Suicide; 125 Merete Nordentoft, Trine Madsen, and Annette Erlangsen: Epidemiology and causes of suicide; 126 Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm: Epidemiology and risk factors; 127 J. John Mann and Dianne Currier: Biological aspects of suicidal behaviour; 128 Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman: Prevention of suicide and treatment following self-harm; Section 22: Somatic symptoms and related disorders; 129 Michael Sharpe and Jane Walker: Deconstructing dualism: The interface between physical and psychological illness; 130 Chantal Berna and Irene Tracey: Neural mechanisms in chronic pain relevant for psychiatric interventions; 131 Jonathan Price: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome; 132 Thomas Merten and Harald Merckelbach: Factitious disorder and malingering; 133 Jon Stone and Michael Sharpe: Functional neurological symptom disorder (Conversion disorder); Section 23: Service provision; 134 Martin Knapp: Public policy and service needs in mental health; 135 Tom Burns and Tony Kendrick: Planning and providing mental health services for a community; 136 Judit Simon: Health economic analysis of service provision; 137 William H. Sledge and Julianne Dorset: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry; 138 Mina Fazel, Susan Rees, and Derrick Silove: Refugees and populations exposed to mass conflict; Section 24: Forensic psychiatry; 139 Seena Fazel and Mark Toynbee: Associations between psychiatric disorder and offending; 140 Sue Bailey and Prathiba Chitsabesan: Developmental approach to understanding the needs of young people in contact with the criminal justice system; 141 Stephen J. Hucker: Child molesters and other sexual offenders; 142 Rosemary Purcell and Paul E. Mullen: Stalking and querulous behaviour; 143 Louise M. Howard and Deirdre MacManus: Domestic violence and abuse and mental health; 144 Alec Buchanan: Assessing and managing the risk of violence towards others; 145 John O Grady: The expert witness in the criminal and civil courts; 146 Matthew Large and Olav Nielssen: Homicide

Trade Policy 买家须知